Oral Oncology
Volume 40, Issue 7 , Pages 736-741 , August 2004

HPV DNA and survivin expression in epithelial oral carcinogenesis: a relationship?

  • Lorenzo Lo Muzio

      Affiliations

    • Institute of Dental Sciences, University of Ancona, Via Toti 4, 60100 Ancona, Italy
    • Corresponding Author InformationCorresponding author. Address: Via Carelli 28, Foggia 71100, Italy. Tel./fax: +39-0881-685809
    • ,
  • Giuseppina Campisi

      Affiliations

    • Department of Oral Sciences, University of Palermo, Via del Vespro 129, 90127 Palermo, Italy
    • ,
  • Lucia Giovannelli

      Affiliations

    • Department of Hygiene and Microbiology, University of Palermo, Via del Vespro 129, 90127 Palermo, Italy
    • ,
  • Pietro Ammatuna

      Affiliations

    • Department of Hygiene and Microbiology, University of Palermo, Via del Vespro 129, 90127 Palermo, Italy
    • ,
  • Immacolata Greco

      Affiliations

    • Department of Experimental Medicine, University L'Aquila, Via Vetoio Coppito 2, 67100 L'Aquila, Italy
    • ,
  • Stefania Staibano

      Affiliations

    • Department of Biomorphological and Functional Sciences, Pathology Unit, University of Naples Federico II, Via Pansini 5, 80131 Naples, Italy
    • ,
  • Giuseppe Pannone

      Affiliations

    • Department of Biomorphological and Functional Sciences, Pathology Unit, University of Naples Federico II, Via Pansini 5, 80131 Naples, Italy
    • ,
  • Gaetano De Rosa

      Affiliations

    • Department of Biomorphological and Functional Sciences, Pathology Unit, University of Naples Federico II, Via Pansini 5, 80131 Naples, Italy
    • ,
  • Chiara Di Liberto

      Affiliations

    • Department of Oral Sciences, University of Palermo, Via del Vespro 129, 90127 Palermo, Italy
    • ,
  • Matteo D'Angelo

      Affiliations

    • Department of Oral Sciences, University of Palermo, Via del Vespro 129, 90127 Palermo, Italy

Received 20 October 2003 ,Accepted 15 November 2003.

References 

  1. Scully C. Oral squamous cell carcinoma; from an hypothesis about a virus, to concern about possible sexual transmission. Oral Oncol. 2002;38(3):227–234
  2. Kojima A, Maeda H, Sugita Y, Tanaka S, Kameyama Y. Human papillomavirus type 38 infection in oral squamous cell carcinomas. Oral Oncol. 2002;38(6):591–596
  3. Uobe K, Masuno K, Fang YR, et al.  Detection of HPV in japanese and chinese oral carcinomas by in situ PCR. Oral Oncol. 2001;37(2):146–152
  4. Elamin F, Steingrimsdottir H, Wanakulasuriya S, Johnson N, Tavassoli M. Prevalence of human papillomavirus infection in premalignant and malignant lesions of the oral cavity in U.K. subjects: a novel method of detection. Oral Oncol. 1998;34(3):191–197
  5. D'Costa J, Saranath D, Dedhia P, Sanghvi V, Mehta AR. Detection of HPV-16 genome in human oral cancers and potentially malignant lesions from India. Oral Oncol. 1998;34(5):413–420
  6. Lo Muzio L, Mignogna MD, Staibano S, et al.  Morphometric study of nucleolar organiser regions (AgNOR) in HPV-associated precancerous lesions and microinvasive carcinoma of the oral cavity. Oral Oncol. 1997;33(4):247–259
  7. Nielsen H, Norrild B, Vedtofte P, Praetorius F, Reibel J, Holmstrup P. Human papillomavirus in oral premalignant lesions. Eur. J. Cancer B Oral Oncol. 1996;32B(4):264–270
  8. Cruz IB, Snijders PJ, Steenbergen RD, et al.  Age-dependence of human papillomavirus DNA presence in oral squamous cell carcinomas. Eur. J. Cancer B Oral Oncol. 1996;32B(1):55–62
  9. Yeudall WA, Paterson IC, Patel V, Prime SS. Presence of human papillomavirus sequences in tumour-derived human oral keratinocytes expressing mutant p53. Eur. J. Cancer B Oral Oncol. 1995;31B(2):136–143
  10. Donofrio V, Lo Muzio L, Mignogna MD, et al.  Prognostic evaluation of HPV-associated precancerous and microinvasive carcinoma of the oral cavity: combined use of nucleolar organiser regions (AgNOR) and proliferating cell nuclear antigen (PCNA). Eur. J. Cancer B Oral Oncol. 1995;31B(3):174–180
  11. Cox M, Maitland N, Scully C. Human herpes simplex-1 and papillomavirus type 16 homologous DNA sequences in normal, potentially malignant and malignant oral mucosa. Eur. J. Cancer B Oral Oncol. 1993;29B(3):215–219
  12. Miller CS, Johnstone BM. Human papillomavirus as a risk factor for oral squamous cell carcinoma: a meta-analysis, 1982–1997. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 2001;91(6):622–635
  13. Giovannelli L, Campisi G, Lama A, et al.  Human papillomavirus DNA in oral mucosal lesions. J. Infect. Dis. 2002;185(6):833–836
  14. Young MR, Farrell L, Lambert P, Awasthi P, Colburn NH. Protection against human papillomavirus type 16-E7 oncogene-induced tumorigenesis by in vivo expression of dominant-negative c-jun. Mol. Carcinog. 2002;34(2):72–77
  15. Ke LD, Adler-Storthz K, Mitchell MF, Clayman GL, Chen Z. Expression of human papillomavirus E7 mRNA in human oral and cervical neoplasia and cell lines. Oral Oncol. 1999;35(4):415–420
  16. Matsukura T, Sugase M. Relationships between 80 Human Papillomavirus Genotypes and Different Grades of Cervical Intraepithelial Neoplasia: Association and Causality. Virology. 2001;283(1):139–147
  17. Skyldberg B, Fujioka K, Hellstrom AC, Sylven L, Moberger B, Auer G. Human papillomavirus infection, centrosome aberration, and genetic stability in cervical lesions. Mod. Pathol. 2001;14(4):279–284
  18. Min BM, Baek JH, Shin KH, Gujuluva CN, Cherrick HM, Park NH. Inactivation of the p53 gene by either mutation or HPV infection is extremely frequent in human oral squamous cell carcinoma cell lines. Eur. J. Cancer B Oral Oncol. 1994;30B(5):338–345
  19. Armstrong DJ, Roman A. The relative ability of human papillomavirus type 6 and human papillomavirus type 16 E7 proteins to transactivate E2F-responsive elements is promoter- and cell-dependent. Virology. 1997;239(1):238–246
  20. Nair P, Nair KM, Jayaprakash PG, Pillai MR. Decreased programmed cell death in the uterine cervix associated with high risk human papillomavirus infection. Pathol. Oncol. Res. 1999;5(2):95–103
  21. Koh JY, Cho NP, Kong G, Lee JD, Yoon K. p53 mutations and human papillomavirus DNA in oral squamous cell carcinoma: correlation with apoptosis. Br. J. Cancer. 1998;78(3):354–359
  22. Itakura M, Mori S, Park NH, Bonavida B. Both HPV and carcinogen contribute to the development of resistance to apoptosis during oral carcinogenesis. Int. J. Oncol. 2000;16(3):591–597
  23. Ambrosini G, Adida C, Altieri DC. A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nat. Med. 1997;3(8):917–921
  24. Lo Muzio L, Staibano S, Pannone G, et al.  Expression of the apoptosis inhibitor survivin in aggressive squamous cell carcinoma. Exp. Mol. Pathol. 2001;70(3):249–254
  25. Adida C, Berrebi D, Peuchmaur M, Reyes-Mugica M, Altieri DC. Anti-apoptosis gene, survivin, and prognosis of neuroblastoma. Lancet. 1998;351(9106):882–883
  26. Kawasaki H, Altieri DC, Lu CD, Toyoda M, Tenjo T, Tanigawa N. Inhibition of apoptosis by survivin predicts shorter survival rates in colorectal cancer. Cancer Res. 1998;58(22):5071–5074
  27. Sarela AI, Macadam RC, Farmery SM, Markham AF, Guillou PJ. Expression of the antiapoptosis gene, survivin, predicts death from recurrent colorectal carcinoma. Gut. 2000;46(5):645–650
  28. Monzo M, Rosell R, Felip E, et al.  A novel anti-apoptosis gene: Re-expression of survivin messenger RNA as a prognosis marker in non-small-cell lung cancers. J. Clin. Oncol. 1999;17(7):2100–2104
  29. Tanaka K, Iwamoto S, Gon G, Nohara T, Iwamoto M, Tanigawa N. Expression of survivin and its relationship to loss of apoptosis in breast carcinomas. Clin. Cancer Res. 2000;6(1):127–134
  30. Ito T, Shiraki K, Sugimoto K, et al.  Survivin promotes cell proliferation in human hepatocellular carcinoma. Hepatology. 2000;31(5):1080–1085
  31. Schwartz SM, Daling JR, Shera KA, et al.  Human papillomavirus and prognosis of invasive cervical cancer: a population-based study. J. Clin. Oncol. 2001;19(7):1906–1915
  32. Ringstrom E, Peters E, Hasegawa M, Posner M, Liu M, Kelsey KT. Human papillomavirus type16 and squamous cell carcinoma of the head and neck. Clin. Cancer Res. 2002;8(10):3187–3192
  33. Gillison ML, Koch WM, Capone RB, et al.  Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J. Natl. Cancer Inst. 2000;92(9):709–720
  34. Herrero R, Castellsague X, Pawlita M, et al.  Human papillomavirus and oral cancer: the International Agency for Research on Cancer multicenter study. J. Natl. Cancer. Inst. 2003;95(23):1772–1783
  35. Frost M, Jarboe EA, Orlicky D, et al.  Immunohistochemical localization of survivin in benign cervical mucosa, cervical dysplasia, and invasive squamous cell carcinoma. Am. J. Clin. Pathol. 2002;117(5):738–744
  36. Lo Muzio L, Pannone G, Staibano S, et al.  Survivin expression in oral squamous cell carcinoma. Br. J. Cancer. 2003;89(12):2244–2248
  37. Lo Muzio L, Pannone G, Leonardi R, et al.  Survivin, a potential early predictor of tumor progression in the oral mucosa. J. Dent. Res. 2003;82(11):923–928
  38. Tanaka C, Uzawa K, Shibahara T, Yokoe H, Noma H, Tanzawa H. Expression of an inhibitor of apoptosis, survivin, in oral carcinogenesis. J. Dent. Res. 2003;82(8):607–611

PII: S1368-8375(04)00028-4

doi: 10.1016/j.oraloncology.2003.11.011

Oral Oncology
Volume 40, Issue 7 , Pages 736-741 , August 2004

Article Tools

* Image Usage & Resolution